IMAX — what changed in the latest 10-Q
A section-by-section comparison of IMAX's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-11-05 vs the prior 10-Q · 2026-07-23
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +92 | −64 | ~57 | 81 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~7 | 6 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Risk factors | Text added/removed | 0 | 0 | ~1 | 20 |
| Other information | Text added/removed | +5 | −4 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-11-05
As a result of the engineering and scientific achievements that are a hallmark of The IMAX Experience®, the Company’s exhibitor customers typically charge a premium for films released in IMAX’s format versus films exhibited in their other auditoriums. The premium pricing, combined with the higher at…
(“global box office”) for the Company’s exhibitor customers and for the movie studios releasing their films to the IMAX network. IMAX has become a key premium distribution and marketing platform for Hollywood and local language films driven by IMAX’s leading global network footprint and scale, the i…
The strength of the IMAX business model and brand are evidenced by its results for the third quarter of 2026, in which the Company delivered the best quarterly financial performance in its history. This includes revenue of $174.6 million, net income of $113.8 million, earnings per diluted share of $…
IMAX generated quarterly box office of $712.1 million, its highest grossing quarter ever led by the performance of Christopher Nolan’s The Odyssey, the first theatrical release ever shot entirely with the IMAX film cameras. The mythic action epic generated IMAX box office of $538 million during the …
Strong demand for IMAX among audiences worldwide continues to create a positive network effect for the Company, as more filmmakers, studios, and artists seek to create content for the IMAX platform. The IMAX film slate for 2027 is more than 65% full and is expected to include more than 12 Filmed For…
Text removed vs the prior filing · source: 10-Q · 2026-07-23
result, IMAX is among the most important and successful global distribution platforms for domestic and international tentpole films. The Company’s global content portfolio includes blockbuster films, both from Hollywood and local language film industries worldwide; IMAX documentaries, both original …
As a result of the engineering and scientific achievements that are a hallmark of The IMAX Experience®, the Company’s exhibitor customers typically charge a premium for films released in IMAX’s format versus films exhibited in their other auditoriums. The premium pricing, combined with the higher at…
The Company achieved global box office of $544.5 million in the first half of 2026. The Company’s first half global box office was derived from 63 new pieces of content distributed across its global network. The first half was highlighted by the performance of the Filmed For IMAX® title Project Hail…
Content Solutions segment results are influenced by the level of commercial success and global box office performance of the films and other content released to the IMAX network, as well as other factors, including the timing of the releases, the timing of documentary downstream sales, the length of…
The Company remains in active negotiations with studios for additional films to fill out its short- and long-term film slate for the IMAX network. The Company also expects to announce additional local language films and exclusive IMAX events and experiences to be released to its global network in 20…
Other information
Text added vs the prior filing · source: 10-Q · 2026-11-05
On September 10, 2026, Robert D. Lister, the Company’s Chief Legal Officer & Senior Executive Vice President, entered into a Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K under the Exchange Act (“Item 408”) and such arrangement, the “Lister Plan”) for the sale of up to 30…
On September 14, 2026, Richard Gelfond, the CEO, entered into a Rule 10b5-1 trading arrangement (as defined in Item 408 and such arrangement, the “Gelfond Plan”) for (i) the sale of 200,000 common shares; (ii) the exercise of 522,979 of stock options granted in January 2019 (the “Options”), which ar…
of 722,979 RSUs on January 4, 2027 (continuing to hold well in excess of his share ownership guidelines). Sales under this Gelfond Plan, which was previously disclosed in a Company subsidiary filing, may commence on December 21, 2026, after the completion of the required cooling-off period under Rul…
On September 14, 2026, Natasha Fernandes, the Company’s Chief Financial Officer, terminated a Rule 10b5-1 trading arrangement adopted on June 26, 2026 that was intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 30,000 common shares of the Company. As of the date of t…
No other Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as defined in Item 408) were adopted or terminated by any directors or officers of the Company during the third quarter of 2026.
Text removed vs the prior filing · source: 10-Q · 2026-07-23
On May 19, 2026, Richard Gelfond, the CEO, entered into a Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K under the Exchange Act (“Item 408”) and such arrangement, the “Gelfond Plan”) for the exercise of 356,757 of stock options granted in June 2016 (the “Options”) and sale…
expiry and are due to expire on January 3, 2027. Sales under this Gelfond Plan, which was previously disclosed in a Company subsidiary filing, may commence on August 18, 2026, after the completion of the required cooling off period under Rule 10b5-1. The Gelfond Plan will terminate on December 31, 2…
On June 26, 2026, Natasha Fernandes, the Company’s Chief Financial Officer, entered into a Rule 10b5-1 trading arrangement (as defined in Item 408) and such arrangement, the “Fernandes Plan”) for the sale of up to 30,000 common shares of the Company. Sales under the Fernandes Plan may commence on Se…
No other Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as defined in Item 408) were adopted or terminated by any directors or officers of the Company during the second quarter of 2026.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice